Status:

COMPLETED

Comparison of DTaP-IPV-Hep B-PRP~T Combined Vaccine to CombAct-HIB® Concomitantly Given With Engerix B® Paediatric and OPV

Lead Sponsor:

Sanofi Pasteur, a Sanofi Company

Conditions:

Hepatitis B

Polio

Eligibility:

All Genders

Up to 3 years

Phase:

PHASE3

Brief Summary

The purpose of this study is to document the immunological response to the investigational hexavalent vaccine at the 6, 10, and 14 weeks schedule The primary objective is to demonstrate that the hexa...

Eligibility Criteria

Inclusion

  • 0 to 3 day old infants
  • Mother seronegative for Human Immunodeficiency Virus (HIV)
  • Born at full term of pregnancy (≥ 37 weeks) with a birth weight ≥ 2.5 kg
  • Apgar score \>7 at 5 or 10 minutes of life
  • Informed consent form signed by a parent or other legal guardian and by an independent witness if the parent or other legal guardian is illiterate
  • Able to attend all scheduled visits and to comply with all trial procedures.

Exclusion

  • Current or planned participation in another clinical trial during the entire duration of the present trial
  • Suspected congenital or acquired immunodeficiency
  • Suspected maternal acute seroconversion syndrome to HIV after 24 weeks gestation based on clinical history
  • Chronic illness at a stage that could interfere with trial conduct or completion
  • Blood or blood-derived products received since birth
  • Any planned vaccination (except Bacille Calmette Guérin and trial vaccinations) from birth to 18 weeks of age
  • Oral Poliovirus Vaccine (OPV) administration at birth
  • Known maternal history of HIV, Hepatitis B (HB) (HbsAg carrier) or Hepatitis C seropositivity
  • Thrombocytopenia or bleeding disorder contraindicating intramuscular (IM) vaccination
  • History of seizures
  • Febrile or acute illness on the day of inclusion.

Key Trial Info

Start Date :

August 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 1 2009

Estimated Enrollment :

622 Patients enrolled

Trial Details

Trial ID

NCT00362336

Start Date

August 1 2006

End Date

August 1 2009

Last Update

May 2 2014

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Soweto, Johannesburg, South Africa, 2013

2

Bertsham, South Africa